| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 02/23/2011 | EP2286844A2 Antibody-drug conjugates and methods |
| 02/23/2011 | EP2286843A2 Compounds for targeting endothelial cells |
| 02/23/2011 | EP2286842A1 Tooth movement activating compound |
| 02/23/2011 | EP2286841A1 Simian adenovirus nucleic acid and amino acid sequences, vectors containing same, and methods of use |
| 02/23/2011 | EP2286834A2 Use of skin penetration enhancers and barrier disruption agents to enhance transcutaneous immune response |
| 02/23/2011 | EP2286830A2 Composition comprising vlp and amyloid-beta peptide |
| 02/23/2011 | EP2286818A1 Fulvestrant formulation |
| 02/23/2011 | EP2286815A2 Methylphenidate Modified Release Formulations |
| 02/23/2011 | EP2286799A2 Microspheres for active embolization |
| 02/23/2011 | EP2286798A1 Protein stabilized pharmacologically active agents, methods for the preparation thereof and methods for the use thereof |
| 02/23/2011 | EP2286796A2 Controlled release formulation comprising albuterol |
| 02/23/2011 | EP2286795A1 Method of producing a cationic liposomal preparation comprising a lipophilic compound |
| 02/23/2011 | EP2286793A2 Pharmaceutical formulations comprising cannabidiol |
| 02/23/2011 | EP2286666A1 Versatile disinfectant |
| 02/23/2011 | EP2285882A1 Polymer microgel beads |
| 02/23/2011 | EP2285881A1 Polymer microgel beads and preparative method thereof |
| 02/23/2011 | EP2285418A1 Stimuli-responsive hydrogel |
| 02/23/2011 | EP2285417A1 Imaging methods and compositions comprising fluorescent dyes associated with viral components for nerve imaging |
| 02/23/2011 | EP2285416A2 Conjugates for the treatment of mesothelioma |
| 02/23/2011 | EP2285415A1 Anti-angiogenic compounds |
| 02/23/2011 | EP2285414A1 Fully synthetic albumin analogue |
| 02/23/2011 | EP2285413A2 A pharmaceutical composition |
| 02/23/2011 | EP2285412A1 Formulations of peg-functionalised serine proteases with high concentrations of an aromatic preservative |
| 02/23/2011 | EP2285411A1 Nicotine lozenge compositions |
| 02/23/2011 | EP2285410A2 Dpp-iv inhibitor combined with a further antidiabetic agent, tablets comprising such formulations, their use and process for their preparation |
| 02/23/2011 | EP2285401A1 Low viscosity compositions comprising a pegylated gla-domain containing protein |
| 02/23/2011 | EP2285399A2 Egf-a domain-mediated modulation of pcsk9 for treating lipid disorders |
| 02/23/2011 | EP2285362A1 Composition for transdermal delivery of cationic active agents |
| 02/23/2011 | EP2285352A2 Atorvastatin compositions |
| 02/23/2011 | EP2285350A2 Methods for the preparation of targeting agent functionalized diblock copolymers for use in fabrication of therapeutic targeted nanoparticles |
| 02/23/2011 | EP2175834B1 Glp-1-fc fusion protein formulation |
| 02/23/2011 | EP1817065B1 Viscoelastic solutions containing sodium hyaluronate and hydroxypropylmethyl- cellulose, preparation and uses |
| 02/23/2011 | EP1634589B1 Aqueous olanexidine solution, method of preparing the same, and disinfectant |
| 02/23/2011 | EP1542723B1 Cross-linkers with high reactivity and solubility and their use in the preparation of conjugates for targeted delivery of small molecule drugs |
| 02/23/2011 | EP1524998B1 Stable aqueous pharmaceutical composition comprising erythropoietin |
| 02/23/2011 | EP1455596B1 Capsule with fast content solubilization and release |
| 02/23/2011 | EP1113819B1 Antibody directed enzyme prodrug therapy (adept) with glucuronidase |
| 02/23/2011 | CN1489456B Pharmacentical formulation |
| 02/23/2011 | CN101981059A Processed starch powder with excellent disintegration properties and manufacturing method thereof |
| 02/23/2011 | CN101981055A Anti-CD79B antibodies and immunoconjugates and methods of use |
| 02/23/2011 | CN101981053A Pegylated Abeta FAB |
| 02/23/2011 | CN101980725A Prodrug comprising a drug linker conjugate |
| 02/23/2011 | CN101980724A Compositions for delivery of cargo such as drugs proteins and/or genetic materials |
| 02/23/2011 | CN101980709A Pyridazine derivatives and their use as therapeutic agents |
| 02/23/2011 | CN101980702A Oral preparation |
| 02/23/2011 | CN101979594A Influenza virus hemagglutinin fusion peptide-containing targeted recombinant molecule gene, protein encoded thereby and application thereof |
| 02/23/2011 | CN101979404A Conserved neutralizing epitope mimic peptide of H5 subtype avian influenza viruses and use thereof |
| 02/23/2011 | CN101979095A Treatment and diagnosis of macrophage mediated disease |
| 02/23/2011 | CN101979094A Method for preparing controlled degradable traditional Chinese medicine collagen and traditional Chinese medicine collagen prepared by same |
| 02/23/2011 | CN101979093A Composition comprising polypeptide-drug substance and other poorly absorbed active ingredient and its use |
| 02/23/2011 | CN101979092A Water-soluble veterinary pharmaceutic adjuvant optimal sugar and preparation process thereof |
| 02/23/2011 | CN101979091A Preparation method of calcium phosphate nano medicament-carrying systems |
| 02/23/2011 | CN101978997A Externally-applied cream for treating wind-heat cold by adopting transdermal absorption technology |
| 02/23/2011 | CN101978988A Chinese medicament aroma agent for promoting human memory |
| 02/23/2011 | CN101978985A Medicament for treating periodontal pocket and sinus |
| 02/23/2011 | CN101978975A Haematococcus extract preparation, and preparation method and use thereof |
| 02/23/2011 | CN101978957A Glucosamine hydrochloride capsule preparation and preparation method thereof |
| 02/23/2011 | CN101978953A Hygroscopic auxiliary material-based solid preparation |
| 02/23/2011 | CN101978945A 一种布洛芬药物组合物 One kind of ibuprofen pharmaceutical composition |
| 02/23/2011 | CN101978944A Water-soluble preparation of anesthetic eugenol for fish and preparation method thereof |
| 02/23/2011 | CN101574323B Migltol microcapsule tablet and preparation method thereof |
| 02/23/2011 | CN101219120B Telmisartan dispersible tablet and method for preparing the same |
| 02/23/2011 | CN101132801B Composition for preparing carbon dioxide preparation for external use |
| 02/22/2011 | US7893297 Amorphous sodium 4-[4-chloro-2-hydroxybenzoyl)amino]butanoate |
| 02/22/2011 | US7893285 Transdermal compositions |
| 02/22/2011 | US7893261 bi-functional organic molecules which combine serotonin transporter reuptake inhibition with serotonin (5-HT, such as 5-HT2A) receptor antagonism in one molecular entity |
| 02/22/2011 | US7893252 Selectively depolymerized galactomannan polysaccharide |
| 02/22/2011 | US7893217 Isolated human antibodies that bind epitopes on RG1 |
| 02/22/2011 | US7893104 Process for synthesizing silver-silica particles and applications |
| 02/22/2011 | US7893054 Materials and methods relating to protein aggregation in neurodegenerative disease |
| 02/22/2011 | US7893033 Targeting proteins to deliver therapeutic or diagnostic reagents |
| 02/22/2011 | US7893023 Prodrugs activated by plasmin and their use in cancer chemotherapy |
| 02/22/2011 | US7892834 Cellular signal-responsive gene transcriptional regulation system |
| 02/22/2011 | US7892786 Methods for expression and purification of immunotoxins |
| 02/22/2011 | US7892582 Composition for oral administration containing capsaicinoids |
| 02/22/2011 | US7892576 Tablets comprising a biologically active substance and an excipient containing calcium carbonate |
| 02/22/2011 | US7892560 Clostridial toxin derivatives able to modify peripheral sensory afferent functions |
| 02/22/2011 | US7892554 Using immunoglobulin fusion to deliver effector cells; tissue targeted therapy; antitumor agents |
| 02/22/2011 | US7892547 Methods and compositions for administering therapeutic and diagnostic agents |
| 02/22/2011 | US7892531 Human serum albumin(HSA); solubilized in low-ionic-strength buffer with specified ph; glycine, aspartic acid, sodium succinate, trehalose; binds with receptors |
| 02/22/2011 | US7892522 Administering contrast-enhancing amount of a contrast agent comprising microbubbles of biocompatible gas stabilised by opsonisable amphiphilic material, allowing liver to take up; generating ultrasound image of liver |
| 02/22/2011 | US7892483 Sterilization process |
| 02/22/2011 | US7891578 Liquid formations for electrohydrodymanic spraying containing polymer and suspended particles |
| 02/22/2011 | CA2583823C Platelet-derived growth factor compositions and methods of use thereof |
| 02/22/2011 | CA2540678C Pharmaceutical compositions for prevention of overdose or abuse |
| 02/22/2011 | CA2501021C Pantethine-containing particulate |
| 02/22/2011 | CA2466726C Preparation composition containing acid-unstable physiologically active compound and process for producing same |
| 02/22/2011 | CA2447181C Vegetable protein-based microcapsules |
| 02/22/2011 | CA2435714C Fenofibrate tablets |
| 02/22/2011 | CA2435503C Flt4(vegfr-3) as a target for tumor imaging and anti-tumor therapy |
| 02/22/2011 | CA2429898C Devices and methods for cholesterol management |
| 02/22/2011 | CA2359109C Methods for treating ovarian cancer, poly(phosphoester) compositions, and biodegradable articles for same |
| 02/22/2011 | CA2350882C Transfection reagents |
| 02/22/2011 | CA2336390C Linear cyclodextrin copolymers |
| 02/22/2011 | CA2263409C High molecular weight polymer-based prodrugs |
| 02/17/2011 | WO2011020107A2 Compositions and methods for detection and treatment of breast cancer |
| 02/17/2011 | WO2011020079A1 Antibodies against human respiratory syncytial virus (rsv) and methods of use |
| 02/17/2011 | WO2011020054A1 Method for modulating the pharmacodynamic effect of orally administered guanylate cyclase receptor agonists |
| 02/17/2011 | WO2011020047A1 Use of il-15 to increase thymic output and to treat lymphopenia |
| 02/17/2011 | WO2011019940A2 Deuterated water and riboflavin solution for extending singlet oxygen lifetimes in treatment of ocular tissue and method for use |